This inventor holds 8 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 11 EPO patents. Top assignees: Novaliq Gmbh, Molecular Health Gmbh. Active years: 2013-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2026
Title: Innovations by Inventor Hartmut Voss
Introduction
Hartmut Voss, an accomplished inventor based in Schriesheim, Germany, has made significant contributions to the field of medicine, particularly in ophthalmic treatments. With a total of six patents to his name, his work focuses on developing innovative compositions that enhance drug delivery and treatment effectiveness for various eye conditions.
Latest Patents
Voss's latest patents demonstrate his pioneering approach in utilizing semifluorinated compounds. One notable invention is directed to compositions comprising semifluorinated compounds and their use as medicaments for topical administration to the eye. This innovation aims to improve the efficacy of treatments for patients needing eye care. Another key patent involves ophthalmic compositions that utilize semifluorinated alkanes specifically for treating keratoconjunctivitis sicca and Meibomian gland dysfunction. His methods emphasize enriching ophthalmic tissue with semifluorinated alkanes, along with delayed release strategies to optimize therapeutic outcomes.
Career Highlights
Throughout his career, Hartmut Voss has collaborated with leading companies in the field. He has worked with Novaliq GmbH, where his research focused on advancements in drug formulations, and Molecular Health GmbH, where he contributed to innovative health technologies. His professional journey exemplifies his commitment to improving patient care through scientific advancements.
Collaborations
Hartmut Voss has had the privilege of working alongside renowned professionals, including Frank Löscher and Dieter Scherer. These collaborations have fostered an environment of innovation, enabling Voss to further develop his groundbreaking ideas and bring them to fruition in the form of patents that benefit the medical community.
Conclusion
With a strong portfolio of patents and a focus on groundbreaking ophthalmic compositions, Hartmut Voss continues to be a prominent figure in the world of medical innovation. His contributions not only enhance the treatment landscape for eye conditions but also inspire future advancements in pharmaceutical formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile